| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-86 |
| filingDate |
1977-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f55e8040cd8d6190e123c3cad7f75ef5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52da3b8f409fdb8158ccb83785ec57a7 |
| publicationDate |
1977-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SE-7710673-L |
| titleOfInvention |
PROCEDURE FOR PREPARING AN ACID ANALOG OF 6-AMINOPENICILLANIC ACID |
| abstract |
In accordance with this invention, it has been found that oxygen analogs of 6.beta.-aminopenicillanic acid and biologically active derivatives thereof can be formed from esters of 6-oxo-penicillanic acid. For example, 6.beta.-phenoxyacetoxypenicillanic acid - an oxygen analog of penicillin V may be formed from an ester of 6-oxopenicillanate. The ester of 6-oxopenicillanic acid is formed by a diiospropyl carbodiimide/dimethyl sulfoxide oxidation of the corresponding ester of 6.alpha.-hydroxypenicillanic acid. The oxygen analogs are formed by reducing the ester of 6-oxo-penicillanic acid to the corresponding 6.beta.-hydroxypenicillanate and then forming the desired analog by acylation. |
| priorityDate |
1973-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |